Given the observed alterations in CKLF1 expression during stroke, our study aimed to investigate whether Rg1 could act as an inhibitor of CKLF1, thereby suppressing its expression and exerting a neuroprotective effect on neural cells. The gene discussed is PPP1R3A; the disease is stroke disorder.